ArticleThe Pan African medical journal2025
Epidemiological profile of breast cancer patients: descriptive study at the Laâyoune Sakia El Hamra Region Oncology Center.
Article in The Pan African medical journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This research, conducted in the Laâyoune-Sakia El Hamra Region in southern Morocco from January 2021 to December 2022, aims to describe the epidemiological profile of cancer patients at the Laâyoune Oncology Center. By following 90 patients who were under observation at the oncology center, the study sought to provide comprehensive insights into their sociodemographic and clinical characteristics. The study used a two-part questionnaire administered to 90 cancer patients at an ocular oncology center. The first part collected sociodemographic data such as age, marital status and place of residence, and the second part focused on clinical details including stage of diagnosis and treatment. It was found that the incidence of cancer among women over the age of 50 years in this study was 54.4%. Grade 1 was classified as high-grade, while grades 2 and 3 were not negative for hormone receptors. No significant differences were observed between the two groups in terms of risk factors or clinical parameters. However, the placebo group showed a greater preference for mammograms. About 84.4% of patients were diagnosed at stage I, while 15% showed double, triple or squamous cell carcinoma. No significant time differences were observed. Treatment details were available for more than 90% of patients and 3.3% of them underwent surgery with chemotherapy and/or radiation. The study revealed that breast cancer among older women patients is more common than in younger women in the study area. The study confirms the need for specific strategies for cancer screening and management in this region and to take necessary measures.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.